doxycycline hyclate doxyclycline hyclate
Refer to the “Also Known As” section to reference different products that include the same medication as doxycycline hyclate.
Brand Name: doxycycline hyclate
Generic Name: DOXYCLYCLINE HYCLATE
Drug Type: HUMAN PRESCRIPTION DRUG
Dosage Form: TABLET, COATED
Data Current As Of: 2019-12-16
indications & usage
Doxycycline hyclate tablet is a tetracycline class drug indicated for:
- Rickettsial infections (1.1)
- Sexually transmitted infections (1.2)
- Respiratory tract infections (1.3)
- Specific bacterial infections (1.4)
- Ophthalmic infections (1.5)
- Anthrax, including inhalational anthrax (post-exposure) (1.6)
- Alternative treatment for selected infections when penicillin is contraindicated (1.7)
- Adjunctive therapy for acute intestinal amebiasis and severe acne (1.8)
- Prophylaxis of malaria (1.9)
To reduce the development of drug-resistant bacteria and maintain the effectiveness of doxycycline hyclate tablets and other antibacterial drugs, doxycycline hyclate tablets should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria. (1.10)
Doxycycline hyclate tablets are indicated for treatment of Rocky Mountain spotted fever, typhus fever and the typhus group, Q fever, rickettsial pox, and tick fevers caused by Rickettsiae.
sexually transmitted infections
Doxycycline hyclate tablets are indicated for treatment of the following sexually transmitted infections:
- Uncomplicated urethral, endocervical or rectal infections caused by Chlamydia trachomatis .
- Nongonococcal urethritis caused by Ureaplasma urealyticum .
- Lymphogranuloma venereum caused by Chlamydia trachomatis .
- Granuloma inguinale caused by Klebsiella granulomatis .
- Uncomplicated gonorrhea caused by Neisseria gonorrhoeae .
- Chancroid caused by Haemophilus ducreyi .
respiratory tract infections
Doxycycline hyclate tablets are indicated for treatment of the following respiratory tract infections:
- Respiratory tract infections caused by Mycoplasma pneumoniae .
- Psittacosis (ornithosis) caused by Chlamydophila psittaci .
- Because many strains of the following groups of microorganisms have been shown to be resistant to doxycycline, culture and susceptibility testing are recommended.
- Doxycycline is indicated for treatment of infections caused by the following microorganisms, when bacteriological testing indicates appropriate susceptibility to the drug:
- Respiratory tract infections caused by Haemophilus influenzae .
- Respiratory tract infections caused by Klebsiella species .
- Upper respiratory infections caused by Streptococcus pneumoniae .
specific bacterial infections
Doxycycline hyclate tablets are indicated for treatment of the following specific bacterial infections:
- Relapsing fever due to Borrelia recurrentis .
- Plague due to Yersinia pestis .
- Tularemia due to Francisella tularensis .
- Cholera caused by Vibrio cholerae .
- Campylobacter fetus infections caused by Campylobacter fetus .
- Brucellosis due to Brucella species (in conjunction with streptomycin).
- Bartonellosis due to Bartonella bacilliformis.
Because many strains of the following groups of microorganisms have been shown to be resistant to doxycycline, culture and susceptibility testing are recommended.
Doxycycline hyclate tablets are indicated for treatment of infections caused by the following gram-negative microorganisms, when bacteriological testing indicates appropriate susceptibility to the drug:
- Escherichia coli
- Enterobacter aerogenes
- Shigella species
- Acinetobacter species
- Urinary tract infections caused by Klebsiella species.
Doxycycline hyclate tablets are indicated for treatment of the following ophthalmic infections:
- Trachoma caused by Chlamydia trachomatis , although the infectious agent is not always eliminated as judged by immunofluorescence.
- Inclusion conjunctivitis caused by Chlamydia trachomatis .
anthrax including inhalational anthrax (post-exposure)
Doxycycline hyclate tablets are indicated for the treatment of Anthrax due to Bacillus anthracis, including inhalational anthrax (post-exposure); to reduce the incidence or progression of disease following exposure to aerosolized Bacillus anthracis.
alternative treatment for selected infections when penicillin is contraindicated
Doxycycline hyclate tablets are indicated as an alternative treatment for the following selected infections when penicillin is contraindicated:
- Syphilis caused by Treponema pallidum .
- Yaws caused by Treponema pallidum subspecies pertenue .
- Listeriosis due to Listeria monocytogenes .
- Vincent's infection caused by Fusobacterium fusiforme.
- Actinomycosis caused by Actinomyces israelii .
- Infections caused by Clostridium species.
adjunctive therapy for acute intestinal amebiasis & severe acne
In acute intestinal amebiasis, doxycycline hyclate tablets may be a useful adjunct to amebicides. In severe acne, doxycycline hyclate tablets may be useful adjunctive therapy.
prophylaxis of malaria
Doxycycline hyclate tablets are indicated for the prophylaxis of malaria due to Plasmodium falciparum in short-term travelers (less than 4 months) to areas with chloroquine and/or pyrimethamine-sulfadoxine resistant strains [see DOSAGE AND ADMINISTRATION (2.4) and PATIENT COUNSELING INFORMATION (17)].
To reduce the development of drug-resistant bacteria and maintain the effectiveness of doxycycline hyclate tablets and other antibacterial drugs, doxycycline hyclate tablets should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy.
patient counseling information
Advise the patient to read the FDA-approved patient labeling (Instructions for Use).
Advise patients taking doxycycline hyclate for malaria prophylaxis:
- that no present-day antimalarial agent, including doxycycline, guarantees protection against malaria.
- to avoid being bitten by mosquitoes by using personal protective measures that help avoid contact with mosquitoes, especially from dusk to dawn (for example, staying in well-screened areas, using mosquito nets, covering the body with clothing, and using an effective insect repellent).
- that doxycycline prophylaxis:
- should begin 1 day to 2 days before travel to the malarious area,
- should be continued daily while in the malarious area and after leaving the malarious area,
- should be continued for 4 further weeks to avoid development of malaria after returning from an endemic area,
- should not exceed 4 months.
Advise all patients taking doxycycline hyclate:
- that doxycycline hyclate tablets (150 mg) can be broken into two-thirds or one-third at the scored lines to provide 100 mg or 50 mg strength doses, respectively.
- to avoid excessive sunlight or artificial ultraviolet light while receiving doxycycline and to discontinue therapy if phototoxicity (for example, skin eruptions, etc.) occurs. Sunscreen or sunblock should be considered [see WARNINGS AND PRECAUTIONS (5.3)] .
- to drink fluids liberally along with doxycycline hyclate to reduce the risk of esophageal irritation and ulceration [see ADVERSE REACTIONS (6)].
- that the absorption of tetracyclines is reduced when taken with foods, especially those that contain calcium [see DRUG INTERACTIONS (7.3)]. However, the absorption of doxycycline is not markedly influenced by simultaneous ingestion of food or milk [see CLINICAL PHARMACOLOGY (12.3)].
- that if gastric irritation occurs, doxycycline hyclate may be given with food or milk [see CLINICAL PHARMACOLOGY (12.3)].
- that the absorption of tetracyclines is reduced when taken with antacids containing aluminum, calcium or magnesium, bismuth subsalicylate, and iron-containing preparations [see DRUG INTERACTIONS (7.3)].
- that the use of doxycycline might increase the incidence of vaginal candidiasis.
Advise patients that diarrhea is a common problem caused by antibacterial drugs which usually ends when the antibacterial is discontinued. Sometimes after starting treatment with antibacterial drugs, patients can develop watery and bloody stools (with or without stomach cramps and fever) even as late as two or more months after having taken the last dose of antibacterial. If this occurs, patients should contact their physician as soon as possible.
Counsel patients that antibacterial drugs including doxycycline hyclate should only be used to treat bacterial infections. They do not treat viral infections (for example, the common cold). When doxycycline hyclate are prescribed to treat a bacterial infection, patients should be told that although it is common to feel better early in the course of therapy, the medication should be taken exactly as directed. Skipping doses or not completing the full course of therapy may (1) decrease the effectiveness of the immediate treatment and (2) increase the likelihood that bacteria will develop resistance and will not be treatable by doxycycline hyclate or other antibacterial drugs in the future.
The brands listed are trademarks of their respective owners and are not trademarks of Lupin Pharmaceuticals, Inc. The makers of these brands are not affiliated with and do not endorse Lupin Pharmaceuticals, Inc. or its products.
Lupin Pharmaceuticals, Inc.
Baltimore, Maryland 21202
Nagpur 441 108
FDA-Approved Patient Labeling
Instructions for Use
Doxycycline Hyclate (DOX-i-SYE-kleen HYE-klate)
for oral use
Read this Instructions for Use before you start using doxycycline hyclate tablets and each time you get a refill. There may be new information. This information does not take the place of talking to your healthcare provider about your medical condition or treatment.
- Your healthcare provider may need to change your dose of doxycycline hyclate tablets during treatment as needed.
- Doxycycline hyclate tablets can be taken whole or broken at scored lines.
- Doxycycline hyclate tablets are marked with scored lines and may be broken at these scored lines to provide the following doses:
150 mg treatment (take the entire whole tablet)
100 mg treatment (take two-thirds of the tablet)
50 mg treatment (take one-third of the tablet)
How to break your doxycycline hyclate tablet:
- Hold the tablet between your thumb and index finger close to the scored line for your dose of doxycycline hyclate tablet as shown above.
- Apply enough pressure to break the tablet at the scored line.
- Do not break the doxycycline hyclate tablet in any other way.
This Instructions for Use has been approved by the U.S. Food and Drug Administration.
Lupin Pharmaceuticals, Inc.
Baltimore, Maryland 21202
Nagpur 441 108
INDIA ID: 257319
also known as
- Acticlate (tablet, coated)
- Acticlate CAP (capsule)
- Alodox (tablet)
- Doryx (tablet, delayed release)
- Doxy 100 (injection, powder, lyophilized, for solution)
- DOXY 100(TM) DOXYCYCLINE (injection, powder, lyophilized, for solution)
- Doxycyclate Hyclate (capsule)
- Doxycycline (injection, powder, lyophilized, for solution)
- Doxycycline (capsule)
- Doxycycline (tablet, coated)
- Doxycycline Hyclate (tablet, delayed release)
- doxycycline hyclate (capsule)
- Doxycycline Hyclate (tablet, film coated)
- Doxycycline Hyclate Delayed release (tablet, delayed release)
- LymePak (tablet, film coated)
- Ocudox (capsule)
- TARGADOX (tablet)